Literature DB >> 2434551

Cross-reactive and unique grass group I antigenic determinants defined by monoclonal antibodies.

R E Esch, D G Klapper.   

Abstract

As part of a study to probe the immunochemical basis for allergenic cross-reactivity among grass pollens, a series of useful reagents has been prepared. The major grass-pollen allergen, designated group I (GpI), was isolated from five grass pollens (meadow fescue, June grass, sweet vernal grass, redtop grass, and perennial ryegrass). The purified GpI antigens were used to immunize individual groups of BALB/c mice. A total of 123 hybridoma-derived anti-GpI monoclonal antibodies (mAbs) was produced. These mAbs were used to evaluate the antigenic relationship among the GpI antigens by means of two types of ELISA. The experiments revealed a high level of epitope diversity and demonstrated a wide range of antibody specificities. A cross-reactivity ELISA was used to identify and compare antigenic determinants on the GpI molecules, and it was possible to define mAbs with specificities unique for the immunizing allergen and other mAbs that cross-reacted with one or more other members of the test panel of allergens. These murine mAbs reflect the range of specificities present in sera from grass-allergic individuals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2434551     DOI: 10.1016/0091-6749(87)90367-8

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  4 in total

Review 1.  Cross-reactivity of plant and animal allergens.

Authors:  R W Weber
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

2.  Isolation of cDNA encoding a newly identified major allergenic protein of rye-grass pollen: intracellular targeting to the amyloplast.

Authors:  M B Singh; T Hough; P Theerakulpisut; A Avjioglu; S Davies; P M Smith; P Taylor; R J Simpson; L D Ward; J McCluskey
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

3.  Recombinant pollen allergens from Dactylis glomerata: preliminary evidence that human IgE cross-reactivity between Dac g II and Lol p I/II is increased following grass pollen immunotherapy.

Authors:  A M Roberts; R Van Ree; S M Cardy; L J Bevan; M R Walker
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

4.  A proteomic style approach to characterize a grass mix product reveals potential immunotherapeutic benefit.

Authors:  Alan Bullimore; Nicola Swan; Wemimo Alawode; Murray Skinner
Journal:  World Allergy Organ J       Date:  2011-09-03       Impact factor: 4.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.